Genome editing has advanced at a rapid pace with promising results for treating genetic conditions -- but there is always room for improvement. A new paper showcases the power of scalable protein ...

By inserting an entire gene, the tool offers a one-and-done approach that overcomes hurdles from CRISPR gene editing technology—which is programmed to correct individual mutations—offering a ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Verve Therapeutics, Inc. (NASDAQ:VERV) stands against other best gene ...

A Kobe University team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms.

Investigators from Mass General Brigham and Beth Israel Deaconess Medical Center have developed STITCHR, a new gene editing tool that can insert therapeutic genes into specific locations without ...

Verve Therapeutics Inc. shares jumped after the company reported no safety issues in a new study of its gene-editing treatment for people with high cholesterol. The Boston-based company said its ...

The latest report published by Report Ocean, titled “Global CRISPR Gene Editing Market“: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024 to 2034,” offers a comprehensive ...

If, of course, society decided that was a good idea. Joung, an early pioneer of the gene-editing technology, was the first to show CRISPR could target and cut DNA inside an embryo — in zebrafish ...

You can reach Elaine on Signal at elaineywchen.70. Verve Therapeutics said initial data show that its investigational gene-editing therapy lowered cholesterol without inducing serious side effects ...

"While we maintain our internal focus, our technology platforms—particularly our ViCas ® CRISPR gene-editing platform and ViLNP ® delivery systems—have proven valuable in advancing ...